Medidata has announced the extension of its 13-year partnership with Tigermed, which will enhance clinical trial processes from early-phase studies to post-marketing surveillance.

Leveraging the Medidata Platform, the partnership will ensure regulatory compliance, improve study workflows, and expedite the delivery of new treatments globally.

Tigermed claims to have conducted more than 300 trials in various therapeutic areas since 2011 using the Medidata Platform.

The extended partnership will build on this experience, integrating the platform further into Tigermed’s workflow to automate data capture and enhance trial efficiency.

Tigermed executive director and co-president Hao Wu said: “Our partnership with Medidata has allowed our customers to make informed, data-driven decisions and achieve milestones faster.

“We are delighted to extend this collaboration and look forward to leveraging more of Medidata’s technologies, including Medidata AI, as we shape the future of clinical trials worldwide.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The Medidata Platform connects contract research organisations (CROs), sites, sponsors, and patients through a scalable and secured cloud environment to provide patients with the required treatments.

This digital solution by Medidata, a Dassault Systèmes brand headquartered in New York City, US, is dedicated to powering smarter treatments and healthier people.

Medidata APAC general manager and senior vice-president Edwin Ng said: “Tigermed exemplifies the evolving role of CROs in driving efficiencies across the clinical trial process.

“Through this partnership, we’re able to jointly push the boundaries of trial management, improving the study experiences, and ultimately delivering better outcomes for patients and sponsors around the world.”

Tigermed offers integrated research and development solutions for the medical devices and biopharmaceutical industries.

Last September, Medidata launched ‘Medidata Patient Payments’ to simplify the process of providing stipends and reimbursements to clinical research participants.